Chief Executive Officer
Dan Spira was a former Vice President at Valeant Pharmaceuticals from 2011 to 2015. This included being based in Australia as the Managing Director of iNova Pharmaceuticals and Bausch + Lomb from 2011 to 2014 and then in North America with responsibility for a portfolio of Valeant owned companies. Prior to that he spent 15 years at Johnson & Johnson in various roles including VP, Country Manager and Chief Marketing Officer.
Dan has now relocated back to Australia and returned as CEO of the iNova group.